AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
María del Pilar Cubría-Juárez
Public Documents
1
Outpatient Administration of Blinatumomab Infusion and Hematopoietic Stem Cell Transp...
Bernabé-Gaspar Luis Eduardo
and 8 more
June 07, 2023
Acute Lymphoblastic Leukemia (ALL) is the most common pediatric cancer and the most common subtype of pediatric leukemia, the high toxicity, relapse and refractory disease of many patients require the development of novel therapeutic approaches. New therapeutic approaches such as targeted immunotherapy in combination with Hematopoietic Stem Cell Transplantation (HSCT) must be taken in count to revolutionize the management of numerous ALL subtypes, improve treatment outcomes and maintain low toxicity without losing the effectiveness of the treatment. We evaluated a novel therapeutic approach in Mexico, the outpatient administration of blinatumomab infusion in patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).